Joaquín Barba

Joaquín Barba

Auto-generated profile, based on publicly available information

Joaquín Barba

Departamento de Cardiología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in The American Journal of Cardiology
Verified
Journal Article
Closed access
EDErnesto Díaz-Infante
Ernesto Díaz-Infante
LMLluís Mont
Lluís Mont
JLJuan Leal
Juan Leal
IGIgnacio García-Bolao
Ignacio García-Bolao
IFIgnacio Fernández-Lozano
Ignacio Fernández-Lozano
JBJosep Brugada
Josep Brugada

1 May 2008 in European Journal of Heart Failure
Verified
Journal Article
Closed access
MVManuel Mazo Vega
Manuel Mazo Vega
VPValérie Planat-Bénard
Valérie Planat-Bénard
GAGloria Abizanda
Gloria Abizanda
BPBeatriz Pelacho
Beatriz Pelacho
BLBertrand Léobon
Bertrand Léobon
FPFelipe Prosper
Felipe Prosper
Aims: To determine the effect of transplantation of undifferentiated and cardiac pre-differentiated adipose stem cells compared with bone marrow mononuclear cells (BM-MNC) in a chronic model of myocardial infarction. Methods: Ninety-five Sprague–Dawley rats underwent left coronary artery ligation and after 1month received by direct intramyocardial injection either adipose derived stem cells (ADSC), cardiomyogenic cells (AD-CMG) or BM-MNC from enhanced-Green Fluorescent Protein (eGFP) mice. The control group was treated with culture medium. Heart function was assessed by echocardiography and 18F-FDG microPET. Cell engraftment, differentiation, angiogenesis and fibrosis in the scar tissue were also evaluated by (immuno)histochemistry and immunofluorescence. Results: One month after cell transplantation, ADSC induced a significant improvement in heart function (LVEF 46.3±9.6% versus 27.7±8% pre-transplant) and tissue viability (64.78±7.2% versus 55.89±6.3% pre-transplant). An increase in the degree of angiogenesis and a decrease in fibrosis were also detected. Although transplantation of AD-CMG or BM-MNC also had a positive, albeit smaller, effect on angiogenesis and fibrosis in the infarcted hearts, this benefit did not translate into a significant improvement in heart function or tissue viability. Conclusion: These results indicate that transplantation of adipose derived cells in chronic infarct provides a superior benefit to cardiac pre-differentiated ADSC and BM-MNC.

1 April 2006 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
JGJuan J. Gavira
Juan J. Gavira
JHJesús Herreros
Jesús Herreros
APAna Pérez
Ana Pérez
MGMaria Garcia-Velloso
Maria Garcia-Velloso
JBJoaquín Barba
Joaquín Barba
FPFelipe Prosper
Felipe Prosper

1 May 2015 in EP Europace
Verified
Journal Article
Closed access
PDF file
NCNaiara Calvo
Naiara Calvo
NSNahikari Salterain
Nahikari Salterain
HAHugo Arguedas
Hugo Arguedas
AMAlfonso Macias
Alfonso Macias
AEAlberto Esteban-Fernández
Alberto Esteban-Fernández
IGIgnacio García-Bolao
Ignacio García-Bolao
Aims Left atrial appendage (LAA) is the source of thrombi in up to 90% of patients with non-valvular atrial fibrillation (AF). Catheter ablation (CA) is an effective treatment for symptomatic AF and, in selected cases, LAA occlusion devices have been introduced as an alternative to oral anticoagulants (OACs). The safety and feasibility of combining CA and percutaneous LAA closure (LAAC) are unknown. Methods and results Patients with symptomatic drug-refractory AF, CHADS2 score of ≥1, and CHA2DS2-VASc score ≥2 were included. Catheter ablation consisted in pulmonary vein isolation with or without roof line with radiofrequency and LAA was occluded with the Watchman or Amplatzer Cardiac Plug (ACP) devices guided by angiography and transoesophageal echocardiography. A total of 35 patients were included (71% male; 70 years). Median score was 3 on both CHA2DS2-VASc and HAS-BLED, 9% had prior stroke under OAC, and 48% had bleeding complications. Successful CA and device implantation were achieved in 97% of cases. The Watchman device was used in 29 patients and ACP in 6 patients. Periprocedural complications included three cases of cardiac tamponade. At 3 months, all patients met the criteria for successful sealing of the LAA. After a mean follow-up of 13 months (3–75), 78% of patients were free of arrhythmia recurrences and OAC was withheld in 97% of patients. Conclusions The combination of CA and percutaneous LAAC in a single procedure is technically feasible in patients with symptomatic drug-refractory AF, high risk of stroke, and contraindications to OACs, although it is associated with a significant risk of major complications.

1 March 2005 in Journal Of Hypertension
Verified
Journal Article
Closed access
BLBegoña López
Begoña López
AGArantxa González
Arantxa González
JLJuan José Lasarte
Juan José Lasarte
PSPablo Sarobe
Pablo Sarobe
FBFrancisco Borrás
Francisco Borrás
JDJavier Díez
Javier Díez
Objective This study was designed to investigate whether plasma concentration of cardiotrophin-1 (CT-1), a cytokine that induces cardiomyocyte hypertrophy and stimulates cardiac fibroblasts, is related to hypertensive heart disease, as defined by the presence of echocardiographically assessed left ventricular hypertrophy (LVH). Methods The study was performed in 31 normotensive subjects and 111 patients with never-treated essential hypertension (54 without LVH and 57 with LVH). Causes of LVH other than hypertension were excluded after a complete medical workup. A novel enzyme-linked immunosorbent assay was developed to measure plasma CT-1. Results Plasma CT-1 was increased (P < 0.001) in hypertensives compared with normotensives. The value of CT-1 was higher (P < 0.001) in hypertensives with LVH than in hypertensives without LVH. Some 31% of patients without LVH exhibited values of CT-1 above the upper normal limit in normotensives. A direct correlation was found between CT-1 and left ventricular mass index (r = 0.319, P < 0.001) in all subjects. Receiver operating characteristic curves showed that a cutoff of 39 fmol/ml for CT-1 provided 75% specificity and 70% sensitivity for predicting LVH with a relative risk of 6.21 (95% confidence interval, 2.95 to 13.09). Conclusions These results show an association between LVH and the plasma concentration of CT-1 in essential hypertension. Although preliminary, these findings suggest that the determination of CT-1 may be an easy and reliable method for the initial screening and diagnosis of hypertensive heart disease.

1 April 2002 in Hypertension
Verified
Journal Article
Closed access
PDF file
AMAlicia M. Maceira
Alicia M. Maceira
JBJoaquín Barba
Joaquín Barba
NVNerea Varo
Nerea Varo
OBOscar Beloqui
Oscar Beloqui
JDJavier Díez
Javier Díez
Elevations in the serum concentration of the carboxy-terminal propeptide of procollagen type I (PIP) >127 μg/L have been found to predict severe myocardial fibrosis in hypertensive patients. This study was designed to assess whether ultrasonic reflectivity, evaluated by a real-time integrated backscatter analysis, was related to the severity of myocardial fibrosis as estimated by serum PIP. Thirty-four subjects were included in the study. Serum PIP was measured by specific radio immunoanalysis. Backscatter cyclic variation and maximal intensity were measured in 6 regions throughout the left ventricle. The subjects were divided into 3 groups: 14 normotensives with PIP <127 μg/L (group 1), 12 hypertensives with PIP 127 μg/L (group 3). The highest cyclic variation was found in group 1 and the lowest in group 3 (5.78±0.25 versus 4.70±0.33 dB, P 127 μg/L in hypertensives, with a relative risk of 2.50 (95% CI, 0.72 to 34.70). These results show an association between diminished cyclic variation of backscatter and increased serum concentration of PIP in hypertension. Thus, the combination of these 2 parameters may be useful for the diagnosis of severe myocardial fibrosis associated with hypertension.